Logo image of BCG

BINAH CAPITAL GROUP INC (BCG) Stock Fundamental Analysis

USA - NASDAQ:BCG - US09032H1059 - Common Stock

2.16 USD
+0.01 (+0.47%)
Last: 10/16/2025, 1:59:22 PM
Fundamental Rating

0

Overall BCG gets a fundamental rating of 0 out of 10. We evaluated BCG against 237 industry peers in the Capital Markets industry. BCG may be in some trouble as it scores bad on both profitability and health. BCG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BCG has reported negative net income.
In the past year BCG has reported a negative cash flow from operations.
In multiple years BCG reported negative net income over the last 5 years.
BCG had negative operating cash flow in 4 of the past 5 years.
BCG Yearly Net Income VS EBIT VS OCF VS FCFBCG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 2M -2M 4M -4M

1.2 Ratios

BCG's Return On Assets of -6.36% is on the low side compared to the rest of the industry. BCG is outperformed by 82.28% of its industry peers.
BCG has a Return On Equity of -23.50%. This is amonst the worse of the industry: BCG underperforms 83.54% of its industry peers.
Industry RankSector Rank
ROA -6.36%
ROE -23.5%
ROIC N/A
ROA(3y)7.78%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BCG Yearly ROA, ROE, ROICBCG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

BCG's Gross Margin of 35.45% is on the low side compared to the rest of the industry. BCG is outperformed by 67.09% of its industry peers.
BCG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BCG Yearly Profit, Operating, Gross MarginsBCG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 5 10 15

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for BCG has been increased compared to 1 year ago.
The debt/assets ratio for BCG is higher compared to a year ago.
BCG Yearly Shares OutstandingBCG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M
BCG Yearly Total Debt VS Total AssetsBCG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

BCG has an Altman-Z score of 1.08. This is a bad value and indicates that BCG is not financially healthy and even has some risk of bankruptcy.
BCG has a Altman-Z score (1.08) which is in line with its industry peers.
A Debt/Equity ratio of 1.44 is on the high side and indicates that BCG has dependencies on debt financing.
BCG has a Debt to Equity ratio of 1.44. This is in the lower half of the industry: BCG underperforms 69.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACCN/A
WACCN/A
BCG Yearly LT Debt VS Equity VS FCFBCG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.75 indicates that BCG may have some problems paying its short term obligations.
With a Current ratio value of 0.75, BCG is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
A Quick Ratio of 0.75 indicates that BCG may have some problems paying its short term obligations.
With a Quick ratio value of 0.75, BCG is not doing good in the industry: 66.24% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
BCG Yearly Current Assets VS Current LiabilitesBCG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for BCG have decreased strongly by -70.59% in the last year.
EPS 1Y (TTM)-70.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.82%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BCG Yearly Revenue VS EstimatesBCG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 50M 100M 150M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BCG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BCG Price Earnings VS Forward Price EarningsBCG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BCG Per share dataBCG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BCG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BINAH CAPITAL GROUP INC

NASDAQ:BCG (10/16/2025, 1:59:22 PM)

2.16

+0.01 (+0.47%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-13 2025-08-13
Earnings (Next)11-03 2025-11-03
Inst Owners2.36%
Inst Owner Change0%
Ins Owners5.52%
Ins Owner Change6.12%
Market Cap35.86M
AnalystsN/A
Price TargetN/A
Short Float %0.54%
Short Ratio0.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.04
Dividend Growth(5Y)N/A
DP-6.8%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.43
P/FCF N/A
P/OCF N/A
P/B 2.01
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.48
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS4.98
BVpS1.07
TBVpS-1.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.36%
ROE -23.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.45%
FCFM N/A
ROA(3y)7.78%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 1.08
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)18.18%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y60.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y66.94%
OCF growth 3YN/A
OCF growth 5YN/A